COVID-19(8) SARS-CoV-2(7) Patient(4) antibody(4) Blood(4) administration(3) second dose(3) impairment(3) immune response(3) healthy(3) Infection(3) BNT162b2(3) IgG level(3) Kidney disease(3) booster(3) high risk(3) South(3) Efficacy(3) pandemic of COVID-19(3) adaptive(3) reached(3) dialysis(3) seropositive(3) dose(3) participant(3) severe acute respiratory syndrome coronavirus 2(3) immune systems(3) vaccination(3) evaluated(3) prospective cohort study(3)